Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · IEX Real-Time Price · USD
22.82
-0.22 (-0.95%)
At close: Jul 19, 2024, 4:00 PM
22.87
+0.05 (0.22%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $2.07 billion as of July 22, 2024. Its market cap has increased by 34.10% in one year.
Market Cap
2.07B
Enterprise Value
1.77B
1-Year Change
34.10%
Ranking
Category
Stock Price
$22.82
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $2.07B, an increase of 2,073.82%. That is a compound annual growth rate of 38.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.07B | -23.33% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.14B |
| Addus HomeCare | 2.12B |
| LifeStance Health Group | 2.10B |
| STAAR Surgical Company | 2.09B |
| Protagonist Therapeutics | 2.09B |
| Premier | 2.05B |
| BrightSpring Health Services | 2.00B |
| Catalyst Pharmaceuticals | 2.00B |